TCL Archive Supreme Court Decision Means FTC Scrutiny As Costly Oncology Drugs Go Off-Patent June 21, 2013
TCL Archive Amgen, Genentech Drug Giveaway Programs Likely to Meet Resistance From Doctors, Potential Problems at CMS. October 13, 2006
TCL Archive RAS Mutations Can Predict Resistance To Vectibix, FOLFOX Combination Treatment September 27, 2013